| (Values in U.S. Thousands) | Mar, 2021 | Mar, 2020 | Mar, 2019 | Mar, 2018 | Mar, 2017 |
| Sales | 290 | 230 | 60 | 0 | 0 |
| Sales Growth | +26.09% | +283.34% | unch | unch | unch |
| Net Income | -3,630 | -3,030 | -1,100 | -40 | -2,270 |
| Net Income Growth | -19.80% | -175.45% | -2,650.07% | +98.24% | +11.67% |
Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Tauriga Sciences, Inc. is a diversified life sciences company focused on the development of a proprietary technology platform in the synthetic biology space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Tauriga Sciences, Inc. is headquartered in Danbury, Connecticut.
Fiscal Year End Date: 03/31